Viva Biotech Holdings (1873.HK)

HKD 0.89

(-2.2%)

Long Term Debt Summary of Viva Biotech Holdings

Viva Biotech Holdings's latest annual long term debt in 2023 was 950.77 Million CNY , up 7.93% from previous year.
Viva Biotech Holdings's latest quarterly long term debt in 2024 Q2 was 861.2 Million CNY , down 0.0% from previous quarter.
Viva Biotech Holdings reported annual long term debt of 880.95 Million CNY in 2022, down -63.11% from previous year.
Viva Biotech Holdings reported annual long term debt of 2.38 Billion CNY in 2021, down -14.67% from previous year.
Viva Biotech Holdings reported quarterly long term debt of 950.77 Million CNY for 2023 Q4, down 0.0% from previous quarter.
Viva Biotech Holdings reported quarterly long term debt of 950.77 Million CNY for 2023 FY, up 7.93% from previous quarter.

Annual Long Term Debt Chart of Viva Biotech Holdings (2023 - 2016)

Historical Annual Long Term Debt of Viva Biotech Holdings (2023 - 2016)

Year	Long Term Debt	Long Term Debt Growth
2023	950.77 Million CNY	7.93%
2022	880.95 Million CNY	-63.11%
2021	2.38 Billion CNY	-14.67%
2020	2.79 Billion CNY	208753.28%
2019	1.34 Million CNY	-99.4%
2018	222.46 Million CNY	9318.5%
2017	2.36 Million CNY	-16.63%
2016	2.83 Million CNY	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	861.2 Million CNY	0.0%
2023 Q4	950.77 Million CNY	0.0%
2023 FY	950.77 Million CNY	7.93%
2023 Q2	589.05 Million CNY	0.0%
2022 FY	880.95 Million CNY	-63.11%
2022 Q4	880.95 Million CNY	0.0%
2022 Q2	2.34 Billion CNY	0.0%
2021 Q2	2.14 Billion CNY	0.0%
2021 FY	2.38 Billion CNY	-14.67%
2021 Q4	2.38 Billion CNY	0.0%
2020 Q4	2.79 Billion CNY	0.0%
2020 FY	2.79 Billion CNY	208753.28%
2020 Q2	538.7 Million CNY	0.0%
2019 Q4	1.34 Million CNY	0.0%
2019 Q2	1.6 Million CNY	0.0%
2019 FY	1.34 Million CNY	-99.4%
2018 Q4	222.46 Million CNY	0.0%
2018 FY	222.46 Million CNY	9318.5%
2017 FY	2.36 Million CNY	-16.63%
2016 FY	2.83 Million CNY	0.0%

Peer Long Term Debt Comparison of Viva Biotech Holdings

Name	Long Term Debt	Long Term Debt Difference
Uni-Bio Science Group Limited	30.61 Million HKD	-3005.893%
CK Life Sciences Int'l., (Holdings) Inc.	4.27 Billion HKD	77.749%